{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T18:23:19Z","timestamp":1748542999059},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,25]]},"DOI":"10.7759\/cureus.19902","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T22:55:56Z","timestamp":1637880956000},"source":"Crossref","is-referenced-by-count":6,"title":["Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C: An International, Multicenter, Randomized Trial"],"prefix":"10.7759","author":[{"given":"Karin","family":"Ried","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taufiq","family":"BinJemain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avni","family":"Sali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109815","article-title":"Does zinc supplementation enhance the clinical efficacy of chloroquine\/hydroxychloroquine to win today's battle against COVID-19?","volume":"142","author":"Derwand R","year":"2020","unstructured":"Derwand R, Scholz M. Does zinc supplementation enhance the clinical efficacy of chloroquine\/hydroxychloroquine to win today's battle against COVID-19?. Med Hypotheses. 2020, 142:109815. 10.1016\/j.mehy.2020.109815","journal-title":"Med Hypotheses"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106214","article-title":"COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study","volume":"56","author":"Derwand R","year":"2020","unstructured":"Derwand R, Scholz M, Zelenko V. COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study. Int J Antimicrob Agents. 2020, 56:106214. 10.1016\/j.ijantimicag.2020.106214","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19","volume":"16","author":"Yang N","year":"2020","unstructured":"Yang N, Shen HM. Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19. Int J Biol Sci. 2020, 16:1724-31. 10.7150\/ijbs.45498","journal-title":"Int J Biol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","volume":"15","author":"Hu TY","year":"2020","unstructured":"Hu TY, Frieman M, Wolfram J. Insights from nanomedicine into chloroquine efficacy against COVID-19. Nat Nanotechnol. 2020, 15:247-9. 10.1038\/s41565-020-0674-9","journal-title":"Nat Nanotechnol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret P","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, et al.. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020, 56:105949. 10.1016\/j.ijantimicag.2020.105949","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","unstructured":"HCQ for COVID- 19. real-time meta analysis of 294 studies. (2021). https:\/\/hcqmeta.com\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4172\/1948-5964.1000173","article-title":"Azithromycin inhibits the replication of Zika virus","volume":"10","author":"Bosseboeuf E","year":"2018","unstructured":"Bosseboeuf E, Aubry M, Nhan T, de Pina JJ, Rolain JM, Raoult D, Musso D. Azithromycin inhibits the replication of Zika virus. J Antivir Antiretrovir. 2018, 10:6-11. 10.4172\/1948-5964.1000173","journal-title":"J Antivir Antiretrovir"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1618029113\/-\/DCSupplemental","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack H","year":"2016","unstructured":"Retallack H, Di Lullo E, Arias C, et al.. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. PNAS. 2016, 113:14408-13. 10.1073\/pnas.1618029113\/-\/DCSupplemental","journal-title":"PNAS"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani J","year":"2020","unstructured":"Andreani J, Le Bideau M, Duflot I, et al.. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020, 145:104228. 10.1016\/j.micpath.2020.104228","journal-title":"Microb Pathog"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2005-82","article-title":"Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data","volume":"51","author":"Tanriverd\u0130 E","year":"2021","unstructured":"Tanriverd\u0130 E, \u00c7\u00f6rt\u00fck M, Yildirim BZ, et al.. Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data. Turk J Med Sci. 2021, 51:10-5. 10.3906\/sag-2005-82","journal-title":"Turk J Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109180","article-title":"Chloroquine is a zinc ionophore","volume":"9","author":"Xue J","year":"2014","unstructured":"Xue J, Moyer A, Peng B, Wu J, Hannafon BN, Ding WQ. Chloroquine is a zinc ionophore. PLoS One. 2014, 9:e109180. 10.1371\/journal.pone.0109180","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmz013","article-title":"The role of zinc in antiviral immunity","volume":"10","author":"Read SA","year":"2019","unstructured":"Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in antiviral immunity. Adv Nutr. 2019, 10:696-710. 10.1093\/advances\/nmz013","journal-title":"Adv Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture","volume":"6","author":"te Velthuis AJ","year":"2010","unstructured":"te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010, 6:e1001176. 10.1371\/journal.ppat.1001176","journal-title":"PLoS Pathog"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.574029","article-title":"The long history of vitamin C: from prevention of the common cold to potential aid in the treatment of COVID-19","volume":"11","author":"Cerullo G","year":"2020","unstructured":"Cerullo G, Negro M, Parimbelli M, et al.. The long history of vitamin C: from prevention of the common cold to potential aid in the treatment of COVID-19. Front Immunol. 2020, 11:574029. 10.3389\/fimmu.2020.574029","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06288-0","article-title":"Effect of vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study","volume":"21","author":"Mahmoodpoor A","year":"2021","unstructured":"Mahmoodpoor A, Shadvar K, Sanaie S, Hadipoor MR, Pourmoghaddam MA, Saghaleini SH. Effect of vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study. BMC Infect Dis. 2021, 21:616. 10.1186\/s12879-021-06288-0","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025876","article-title":"High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: a protocol for systematic review and meta-analysis","volume":"100","author":"Huang L","year":"2021","unstructured":"Huang L, Wang L, Tan J, Liu H, Ni Y. High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021, 100:e25876. 10.1097\/MD.0000000000025876","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.638556","article-title":"High dose intravenous vitamin C for preventing the disease aggravation of moderate COVID-19 pneumonia. a retrospective propensity matched before-after study","volume":"12","author":"Zhao B","year":"2021","unstructured":"Zhao B, Liu M, Liu P, et al.. High dose intravenous vitamin C for preventing the disease aggravation of moderate COVID-19 pneumonia. a retrospective propensity matched before-after study. Front Pharmacol. 2021, 12:638556. 10.3389\/fphar.2021.638556","journal-title":"Front Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau AR","year":"2017","unstructured":"Martineau AR, Jolliffe DA, Hooper RL, et al.. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017, 356:i6583. 10.1136\/bmj.i6583","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00513","article-title":"A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency","volume":"8","author":"Benskin LL","year":"2020","unstructured":"Benskin LL. A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency. Front Public Health. 2020, 8:513. 10.3389\/fpubh.2020.00513","journal-title":"Front Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aimed.2021.01.003","article-title":"Vitamin-D and COVID-19: time for the profession to take a stand","volume":"8","author":"Brighthope I","year":"2021","unstructured":"Brighthope I, Sali Am A, Ried K. Vitamin-D and COVID-19: time for the profession to take a stand. Adv Integr Med. 2021, 8:77-8. 10.1016\/j.aimed.2021.01.003","journal-title":"Adv Integr Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02488-5","article-title":"The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19","volume":"18","author":"Xu Y","year":"2020","unstructured":"Xu Y, Baylink DJ, Chen CS, et al.. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020, 18:322. 10.1186\/s12967-020-02488-5","journal-title":"J Transl Med"},{"key":"ref22","unstructured":"Meta-analysis of vitamin C Covid-19 treatment studies. (2021). https.\/\/c19vitaminc.com\/."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0369","article-title":"Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial","volume":"4","author":"Thomas S","year":"2021","unstructured":"Thomas S, Patel D, Bittel B, et al.. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical trial. JAMA Netw Open. 2021, 4:e210369. 10.1001\/jamanetworkopen.2021.0369","journal-title":"JAMA Netw Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2021_119","article-title":"The prognostic significance of vitamin D deficiency in patients with COVID-19 pneumonia","volume":"122","author":"Yildiz M","year":"2021","unstructured":"Yildiz M, Senel MU, Kavurgaci S, Ozturk FE, Ozturk A. The prognostic significance of vitamin D deficiency in patients with COVID-19 pneumonia. Bratisl Lek Listy. 2021, 122:744-7. 10.4149\/BLL_2021_119","journal-title":"Bratisl Lek Listy"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-021-02482-5","article-title":"The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection","volume":"203","author":"Matin S","year":"2021","unstructured":"Matin S, Fouladi N, Pahlevan Y, et al.. The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection. Arch Microbiol. 2021, 203:5153-62. 10.1007\/s00203-021-02482-5","journal-title":"Arch Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15495","article-title":"Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study","volume":"287","author":"Merzon E","year":"2020","unstructured":"Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, Frenkel-Morgenstern M. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020, 287:3693-702. 10.1111\/febs.15495","journal-title":"FEBS J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa733","article-title":"Vitamin D status in hospitalized patients with SARS-CoV-2 infection","volume":"106","author":"Hern\u00e1ndez JL","year":"2021","unstructured":"Hern\u00e1ndez JL, Nan D, Fernandez-Ayala M, et al.. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab. 2021, 106:e1343-53. 10.1210\/clinem\/dgaa733","journal-title":"J Clin Endocrinol Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1101\/2021.09.22.21263977","article-title":"COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng\/ml 25 (OH) D3: results of a systematic review and meta-analysis","volume":"13","author":"Borsche L","year":"2021","unstructured":"Borsche L, Glauner B, Mendel Jv. COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng\/ml 25 (OH) D3: results of a systematic review and meta-analysis. Nutrients. 2021, 13:3596. 10.1101\/2021.09.22.21263977","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.aimed.2015.11.002","article-title":"Integrative health check reveals suboptimal levels in a number of vital biomarkers","volume":"2","author":"Travica N","year":"2015","unstructured":"Travica N, Ried K, Bujnowski R, Sali A. Integrative health check reveals suboptimal levels in a number of vital biomarkers. Adv Integr Med. 2015, 2:135-40. 10.1016\/j.aimed.2015.11.002","journal-title":"Adv Integr Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.22038\/abjs.2020.47754.2346","article-title":"Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis","volume":"8","author":"Baradaran A","year":"2020","unstructured":"Baradaran A, Ebrahimzadeh MH, Baradaran A, Kachooei AR. Prevalence of comorbidities in COVID-19 patients: a systematic review and meta-analysis. Arch Bone Jt Surg. 2020, 8:247-55. 10.22038\/abjs.2020.47754.2346","journal-title":"Arch Bone Jt Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76496-therapies-to-prevent-progression-of-covid-19-including-hydroxychloroquine-azithromycin-zinc-and-vitamin-d3-with-or-without-intravenous-vitamin-c-an-international-multicenter-randomized-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:05Z","timestamp":1707507065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76496-therapies-to-prevent-progression-of-covid-19-including-hydroxychloroquine-azithromycin-zinc-and-vitamin-d3-with-or-without-intravenous-vitamin-c-an-international-multicenter-randomized-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.19902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}